Ari Rosenberg at #asco24 sharing a first look at TARGET-HPV. Exciting HPV targeted chemo-immunotherapy neoadjuvant treatment with adaptive de-escalation. A great multi-D effort from UChicagoCancerCenter University of Chicago Hematology/Oncology UChicagoOHNS University of Chicago Radiation Oncology

Ari Rosenberg presents results from HB-200, an arenavirus-based vector therapy specifically targeted for HPV+ oropharyngeal cancers. Neoadjuvant HB-200 could be a potential new therapy as induces T-cell responses and reduces ctHPV-DNA. #ASCO24 UChicagoCancerCenter UChicago Medicine

Ari Rosenberg, MD discusses the clinical studies testing the efficacy and safety profile of novel and emerging therapies using #BispecificAntibodies, #FusionProteins, and #MultikinaseInhibitors. Ari Rosenberg UChicagoOHNS UChicagoCancerCenter University of Chicago Hematology/Oncology

Ari Rosenberg describing our future anti-cancer weapons portfolio in the fight against #hncsm at today's #ASCO24 education session.

Excellent presentation by Pearson Lab of pathway study #ASCO24 demonstrating improved PFS with pembrolizumab vs placebo in high risk #headandneckcancer particularly among salvage surgery and multiply recurrent subsets UChicagoCancerCenter

Today at #ASCO24, Alexander Pearson, MD presented the results from #PATHway study showing significant improvement in PFS but not in OS with immunotherapy, #Pembrolizumab treatment in high risk #HeadAndNeckSquamousCellCarninoma pts. Pearson Lab UChicagoOHNS UChicagoCancerCenter

In this episode of #OncLiveOnAir, Ari Rosenberg, UChicago Medicine, discusses strategies for managing nasopharyngeal cancer and the role of toripalimab in this treatment paradigm. #oncology #medtwitter onclive.com/view/rosenberg…

In this episode of #OncLiveOnAir,Ari Rosenberg, of UChicago Medicine, discusses strategies for managing nasopharyngeal cancer and the role of toripalimab in this treatment paradigm. #oncology #medtwitter onclive.com/view/rosenberg…

Starting Now: Novel Bispecifics, ADCs, and Radiation Sensitizers in Head and Neck Cancer Moderated by: Hossein Borghaei, DO #DAVAHawaiiLung

Starting Now: Translational Biology Moderated by: Robert Haddad #DAVAHawaiiLung

Thank you, DAVA Oncology , for having this amazing Head & Neck Crew at the 3rd Hawaii Summit on Thoracic Oncology (now with a head and neck section)!

U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefront/news…

Experts at UChicago Medicine successfully treated and cured stage IV oral cancer patient Pat Sirvinskas with a unique approach that spared her tongue. Hear her story in her own words. Nishant Agrawal Ari Rosenberg Aditya Juloori UChicagoOHNS ow.ly/ksE550SPooT

🔍 Check out the new episode on Head and Neck Cancer with Ari Rosenberg from the University of Chicago Ari Rosenberg 🎧 Unveiling the Invisible Enemy: Head and Neck Cancer Insights 🎤 Available via: medinsightsunleashed.com/unveiling-the-… #hnscc #headandneckcancer

🔍 Check out the new episode on Head and Neck Cancer with Ari Rosenberg from the University of Chicago Ari Rosenberg 🎧 Unveiling the Invisible Enemy: Head and Neck Cancer Insights 🎤 Available via: medinsightsunleashed.com/unveiling-the-… #hnscc #headandneckcancer